← Back to Discover

GILEAD SCIENCES, INC.

Period ended Sep 30, 2026 · Latest filing Nov 6, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Sep 30, 2026: $1,463,841,605

More quarters will appear as history becomes available.

Top holdings

Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. Arcus Biosciences Inc. · COM · 03969F109 · shares: $811,701,551
  2. Lakefront Biotherapeutics · SPON ADR · 36315X101 · shares: $501,284,604
  3. Assembly Biosciences Inc. · COM NEW · 045396207 · shares: $116,911,821
  4. Kyverna Therapeutics Inc. · COM · 501976104 · shares: $28,057,609
  5. Xilio Therapeutics Inc. · COM · 98422T100 · shares: $5,886,020

Reported holdings

5 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
Arcus Biosciences Inc.COM03969F109 — 31,424,760 shares $811,701,551
Lakefront BiotherapeuticsSPON ADR36315X101 — 16,707,477 shares $501,284,604
Assembly Biosciences Inc.COM NEW045396207 — 4,977,089 shares $116,911,821
Kyverna Therapeutics Inc.COM501976104 — 4,126,119 shares $28,057,609
Xilio Therapeutics Inc.COM98422T100 — 650,389 shares $5,886,020